Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Instrumentation and Procedure Scientific Consultation

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract, titled Instrumentation and Procedure Scientific Consultation, provides professional scientific and technical advisory services to prime contractors supporting NIH/NCI cancer diagnostic projects. The scope of work focuses on delivering expert guidance from scientists and engineers regarding the utilization of Roche Ventana Benchmark ULTRA units, specifically focusing on instrumentation optimization and the development of procedures for immunohistochemistry and in situ hybridization. Managed under the National Institutes of Health within the Department of Health and Human Services, the contract is categorized under NAICS code 541715. The place of performance is located in Bethesda, Maryland. The solicitation was posted on October 22, 2026, with a response deadline of October 28, 2026.

General Info

Scientific consultation for NIH/NCI cancer diagnostics using Roche Ventana Benchmark ULTRA units.

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

This scope was carved out of PCA-NCI-04352.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Reagents and consumables for Roche immunostainers

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Provides professional scientific consultation for prime contractors on NIH/NCI cancer diagnostic projects. Delivers technical guidance from scientists and engineers on the use of Roche Ventana Benchmark ULTRA units. Consults on instrumentation optimization and procedure development for immunohistochemistry and in situ hybridization. Delivers technical advisory services.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
ACC-DTA Commercial Solutions Opening (CSO)
Solicitation # W912CH-26-S-0001
The Army Contracting Command – Detroit Arsenal (ACC-DTA) Commercial Solutions Opening (CSO), solicitation W912CH-26-S-0001, serves as a rapid-acquisition gateway to transition cutting-edge commercial technologies into active defense programs. This vehicle supports a diverse customer base, including the Intelligence and Security Command (INSCOM) and six Portfolio Acquisition Executives, focusing on the development, integration, and sustainment of ground vehicle systems to enhance Army modernization and readiness. The CSO utilizes a streamlined, merit-based, multi-phased evaluation process consisting of solution briefs, presentations, and commercial solution proposals. Awards may be issued through 2028 as FAR Part 12 contracts or non-FAR agreements, such as Other Transaction Authority (OTA) and Cooperative Agreements. The solicitation is organized around various Areas of Interest (AoI) that address critical military needs. Key initiatives include the FALCONS prototype effort for long-range reconnaissance sensors with funding ceilings between 24 million and 30 million dollars, the TIGER Readiness and Hackathon programs for Abrams Main Battle Tank engine supply chain resilience, and requirements for Counter-Unmanned Aircraft Systems (C-UAS) detection, Mobile Camouflage Systems, and Light Tactical Trailer Heavy Chassis. Technical evaluations focus on mission viability and prototype execution, while price proposals are assessed for affordability. To be eligible for award, companies must be registered in the System for Award Management (SAM) with a Unique Entity ID and comply with the Buy American Act and Specialty Metals clauses.
W6QK Acc- Dta

POSTED

about 8 hours ago

DEADLINE

in about 2 years
View Details
NAICS: 541715
New
Federal
BAA DEVCOM AC Emerging Technologies
Solicitation # W15QKN-26-S-1AZR
The U.S. Army Combat Capabilities Development Command Armaments Center is soliciting research proposals and white papers for new and innovative technologies related to emerging weapons, munitions systems, and soldier lethality. Issued under FAR 6.102(d)(2), this Broad Agency Announcement is a continuously open solicitation effective from March 5, 2026, through March 4, 2031. The program seeks to advance the state of the art through collaborations with industry and academia, with a particular interest in scientific study and experimentation that fills technology needs across the product life cycle, including improvements in armament packaging, ammunition logistics, and micro-system architecture. The submission process is a two-stage effort beginning with a white paper, which is limited to six pages plus a cover page and biographical sketches. Offerors whose white papers are favorably evaluated may be invited to submit a full research proposal. The government prefers proposals covering a three-year period of performance with incremental funding. Awards are based on a competitive selection process evaluating overall scientific and technical merit, potential contributions to the Army mission, offeror capabilities, personnel qualifications, past performance, and proposed price. All submissions must be unclassified and adhere to strict formatting guidelines, including 12-point Times New Roman font for narrative text.
W6QK Acc-Ri-Picatinny

POSTED

about 8 hours ago

DEADLINE

in over 4 years
View Details
NAICS: 541715
New
Federal
Common Autonomous Multi-Domain Launcher (CAML)-Lite Prototype Effort
Solicitation # W50RAJ27CAML_LITE
The Common Autonomous Multi-Domain Launcher (CAML)-Lite Prototype Effort is a competitive procurement conducted under 10 U.S.C. section 4022 for the development of a mobile, optionally manned, autonomous launcher designed to increase survivability and reduce manned support for cross-domain fires. Managed by the Department of Defense, this effort utilizes Other Transaction Agreements (OTAs) and follows a two-phase structure. Phase 1 focuses on a government-sponsored prototype demonstration at Talisman Sabre 2027 in August 2027, with options for the government to acquire additional prototype units, new equipment training, and contractor logistics support. Phase 2 involves maturing selected solutions into a production-representative configuration integrated into a common CAML architecture. The procurement process begins with a Request for Solutions Brief to identify meritorious respondents, who will then be invited to submit a Request for Prototype Proposal. Key technical requirements include the use of a Modular Open Systems Approach (MOSA) to ensure interchangeable modules and common interfaces. Performers are required to assume full responsibility for international logistics and compliance for the Phase 1 demonstration and must adhere to minimum Right to Repair requirements as a condition of award. Selection for Phase 1 is based on the feasibility of the maturation path and the technical soundness of the approach, while subsequent option exercises will prioritize speed of delivery, technical performance, property rights, and the right to repair. Phase 1 OTA awards are expected by December 18, 2026, with a firm-fixed-price payment structure split between award and demonstration completion.
W6DV Peo M & S Redstone

POSTED

1 day ago

DEADLINE

in 1 day
View Details
NAICS: 541715
New
Federal
Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-160
The Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS) program, under solicitation ARPA-H-SOL-26-160, is an initiative by the Advanced Research Projects Agency for Health (ARPA-H) to develop a near real-time, non-destructive, AI-enabled screening system. The goal is to identify contamination, adulteration, and quality defects in pharmaceutical products through their packaging at ports of entry and other supply-chain nodes using multi-modal sensing and data fusion. This 54-month program is structured into three 18-month phases, culminating in a fieldable platform with validated training materials and integrated documentation capabilities. This procurement is conducted as a multiple-award Other Transaction (OT) Agreement rather than a standard federal contract, meaning it is governed by specific OT articles instead of the Federal Acquisition Regulation. Awards are based on the most advantageous proposals, with primary evaluation factors including innovation, soundness, execution planning, risk management, and team expertise. Payments are fixed and triggered by the successful completion of milestones, managed through the Payment Management System. Proposers must be registered in SAM.gov and provide detailed technical and cost proposals, including a milestone payment schedule and research security disclosures. Amendment 01 specifically updated the cost proposal narrative model and workbook to correct typographical errors and rename appendices.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

1 day ago

DEADLINE

in 19 days
View Details
NAICS: 541715
New
Federal
STAR-FISH CALL 017 - Secure By Design
Solicitation # FA945326XA001
The Air Force Research Laboratory, Space Vehicles Directorate, is soliciting white papers under CALL 017 of the Space Technology Advanced Research - Fast-tracking Innovative Software and Hardware (STAR-FISH) program. This effort, titled Secure by Design Space Vehicle (SDSV), aims to mitigate cyber threats to critical national space missions, including PNT, MW/MT, ISR, and SATCOM, by developing a comprehensive cyber-hardened space vehicle system. The scope of work involves the research, design, and demonstration of a hardware-based flat-sat and a corresponding cyber range targeting P-LEO missions. Key objectives include the integration of cyber-hardened flight software, the development of cyber detection and recovery courses of action, and the execution of both ground-based and live on-orbit experimentation. This is a two-step procurement process requiring an initial unclassified white paper and a rough order of magnitude cost estimate, due by 1600 MST on November 13, 2026. Selected offerors will then be invited to submit full proposals. The government anticipates awarding multiple Cost Plus Fixed Fee (CPFF) contracts with a total funding profile of 14 million dollars distributed from FY2027 through FY2030. Awards will include a base period and two option periods. Evaluation will be based on a weight of scientific evidence approach, prioritizing technical merit and relevance to DOD missions over cost realism. Offerors must maintain an approved accounting system per FAR 16.301-3 and provide a detailed organizational conflict of interest analysis. Security requirements range from CUI to Secret, and all payment requests must be processed through the Wide Area WorkFlow system.
FA9453 Afrl Rvk

POSTED

1 day ago

DEADLINE

in 22 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 325413
New
Federal
Reagents and consumables for Roche immunostainers
Solicitation # PCA-NCI-04352
The National Institutes of Health, under the Department of Health and Human Services, is issuing a Sources Sought Notice for a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract to provide reagents, consumables, and software upgrades for the Laboratory of Pathology at the Cancer Center Research. The required materials must be compatible with four Roche Ventana Medical Systems Benchmark ULTRA immunostainers to support immunohistochemical and in situ hybridization testing for cancer diagnostics and research. The contract is expected to include a base period starting December 1, 2026, and ending November 30, 2027, with four subsequent option periods. Key performance requirements include the delivery of reagents within five days of a task order, with all supplies featuring expiration dates extending more than 12 months beyond the shipping date. Reagents must be shipped overnight using dry ice, wet ice, or other industry best practices to the performance site in Bethesda, Maryland. Additionally, the contractor must provide no-cost software upgrades within one month of release, including technologist training and access to scientists and engineers for consultation. Award will be based on a best value tradeoff for offerors meeting the minimum requirements. Interested small businesses must submit a capability statement of no more than seven pages to Luz Casey by October 28, 2026.
In-Vitro Diagnostic Substance Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 334516
New
Federal
NOI - 4D-Nucleofector Core Unit and X Unit
Solicitation # 75N98027Q00025
The National Institutes of Health Office of the Director, Office of Acquisitions, is issuing solicitation 75N98027Q00025 as a Notice of Intent to award a non-competitive, firm-fixed-price purchase order for the procurement of a Lonza 4D-Nucleofector Core Unit (Part No. AAF-1003B) and X Unit (Part No. AAF-1003X), each including a one-year warranty extension. This brand-name acquisition is conducted under FAR 12.603 and is not expected to exceed the simplified acquisition threshold. The equipment is required to maintain continuity and reproducibility in studies involving the introduction of genetic material into primary and difficult-to-transfect cell types. The government intends to negotiate with Lonza Walkersville, Inc., although other responsible sources may submit capability statements and quotations by November 5, 2026. The requirement is categorized under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing and is not set aside for small businesses. Eligible respondents must be registered in the System for Award Management and provide their Unique Entity Identifier, Taxpayer Identification Number, and business size certification. Evaluation factors include technical capability to provide the specific part numbers, manufacturer or authorized reseller status, manufacturer-supported warranty coverage, delivery timeframe, and total price. Delivery is requested as soon as possible to the NIH facility in Bethesda, Maryland, on an F.O.B. Destination basis. All invoicing must be processed through the Invoicing Processing Platform using a three-way match.
Analytical Laboratory Instrument Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 14 days
View Details
NAICS: 811210
New
Federal
NOI - Maintenance and Service Agreement for Thermo
Solicitation # 75N98027Q00023
The National Institutes of Health (NIH) Office of the Director intends to award a non-competitive, firm-fixed-price purchase order for a one-year maintenance and service agreement covering one ThermoFisher Scientific Talos L120C Transmission Electron Microscope. This acquisition, identified by solicitation number 75N98027Q00023, is conducted under the authority of FAR 12.603 and is not set aside for small business. The period of performance is scheduled from November 9, 2026, to November 8, 2027, with services performed at the Clinical Research Center in Bethesda, Maryland. ThermoFisher Scientific is identified as the sole source capable of providing the required factory-trained engineers, proprietary software, firmware, and OEM-specification parts necessary to maintain the instrument. The scope of work includes one scheduled annual preventive maintenance visit, unscheduled corrective repair services including all parts and labor, and remote diagnostic and telephone support. Deliverables include the provision of specific PM consumables and written service reports following each visit to verify the instrument is operating within manufacturer specifications. Invoicing must be processed through the Invoicing Processing Platform (IPP) using a three-way match and submitted on an annual basis. Proposals are due by November 5, 2026, and must include the offeror's Unique Entity Identifier, business size certification, and active SAM registration.
Electronic and Precision Equipment Repair and Maintenance

POSTED

about 8 hours ago

DEADLINE

in 14 days
View Details
NAICS: 325413
New
Federal
NOI - DNA Sequencing of Bone Marrow Failure Syndro
Solicitation # 75N98027Q00027
The National Institutes of Health, Office of the Director, intends to award a non-competitive, firm-fixed-price purchase order for custom-designed ArcherDX VariantPlex Next-Generation Sequencing target-enrichment library preparation kits. This acquisition, conducted under solicitation 75N98027Q00027, is designated for the NHLBI Hematology Branch to support the screening of over 200 patient samples for aplastic anemia and bone marrow failure syndromes. The government intends to negotiate with Integrated DNA Technologies, Inc. as the sole owner and manufacturer of the proprietary ArcherDX VariantPlex Anchored Multiplex PCR chemistry, which is essential for maintaining scientific continuity and compatibility with existing bioinformatics pipelines and Illumina NovaSeq instruments. The requirement falls under NAICS code 325413 and is not set aside for small businesses. The kits must feature pre-amplification ligation of unique molecular barcodes to enable error-correcting sequencing and must be delivered to Bethesda, Maryland, within an estimated turnaround time of four to six weeks after receipt of order. Proposals must be submitted by November 2, 2026, and include a Unique Entity Identifier, Taxpayer Identification Number, and business size certification. Award evaluation may consider technical capability, past performance, and lifecycle expectations, while all invoicing must be processed through the Invoicing Processing Platform using a three-way match.
In-Vitro Diagnostic Substance Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 11 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS